XML 117 R32.htm IDEA: XBRL DOCUMENT
v3.20.1

Nature of business (Table) | 12 Months Ended
--- | ---
Dec. 31, 2019
Disclosure of Nature of business [abstract] |
Schedule of ownership percentage in subsidiaries |
|  |  | Ownership |  |  | Ownership |
|  |  | percentage |  |  | percentage |
Entity Name | Country |  | December 31, 2019 |  |  | December 31, 2018 |
|  |  | % |  |  | % |
FV Pharma Inc. | Canada |  | 100 |  |  | 100 |
Prismic Pharmaceuticals Inc. | USA |  | 100 |  |  | — |

X
- Definition Represents Nature of business abstract. + References No definition available. + Details
Name: | huge_DisclosureOfNatureOfBusinessAbstract
Namespace Prefix: | huge_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of subsidiaries. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 17 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_17_b&doctype=Standard -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 16 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_16_b&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph B4 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration